AU2900295A - Peptide, a method of obtaining it and a pharmaceutical compound based on it - Google Patents
Peptide, a method of obtaining it and a pharmaceutical compound based on itInfo
- Publication number
- AU2900295A AU2900295A AU29002/95A AU2900295A AU2900295A AU 2900295 A AU2900295 A AU 2900295A AU 29002/95 A AU29002/95 A AU 29002/95A AU 2900295 A AU2900295 A AU 2900295A AU 2900295 A AU2900295 A AU 2900295A
- Authority
- AU
- Australia
- Prior art keywords
- cys
- ala
- peptide
- orn
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
The invention is a peptide of general formula (I) X-Tyr-Y-Phe-Z-A, wherein: X represents H or Arg, D-Arg, Orn, D-Orn, Lys, D-Lys, Har, D-Har, Cyt, D-Cyt; Y represents D-Ala, D-Val, D-Leu, D-Ile, D-Phe, D-Asn, D-Trp, D-Pro, D-Ser, D-Thr, D-Tyr, D-Hyp, D-Cys, D-Cys-Cys, D-Met, D-Lys, D-Har, D-Arg, D-His, D-Asp, D-Glu, D- beta -Ala, D-Orn; Z represents Ala, D-Ala, Val, D-Val, Leu, D-Leu, Ile, D-Ile, Phe, D-Phe, Asn, D-Asn, Gly, Gln, D-Gln, Trp, D-Trp, Pro, D-Pro, Ser, D-Ser, Thr, D-Thr, Tyr, D-Tyr, Hyp, D-Hyp, Cys, D-Cys, Cys-Cys, Cys-D-Cys, D-Cys-Cys, D-Cys-D-Cys, Met, D-Met, Lys, D-Lys, Arg, D-Arg, His, D-His, Asp, D-Asp, Glu, D-Glu, beta -Ala, D- beta -Ala, Orn, D-Orn; and A represents OH or a substituted amide (C1-C3). According to the invention, the proposed peptide of general formula (I) is obtained by the gradual construction of a peptide chain, starting from C-terminated amino acide Z, in the form of a substituted amide or carboxyl-protected group, by addition using the method of activated ethers or mixed anhydrides of a successive N-protected amino acid; the N-protective group is split off and the successive N-protected amino acid is re-added to produce a tetra- or pentapeptide which is unblocked in the presence of a palladium catalyst, and the target product is separated out. The proposed peptide and a compound based on it can be used as an agent with pronounced opiate-like properties and also has anabolic properties which increase body weight as well as promoting activity in the growing zones and development of the epidermal layer including the hair. The bio-stimulating properties of the claimed peptide are also evident in the healing of wounds and repair processes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RO94024278 | 1994-06-29 | ||
RU9494024278A RU2067000C1 (en) | 1994-06-29 | 1994-06-29 | Peptide and a method of its synthesis |
PCT/RU1995/000138 WO1996002267A1 (en) | 1994-06-29 | 1995-06-27 | Peptide, a method of obtaining it and a pharmaceutical compound based on it |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2900295A true AU2900295A (en) | 1996-02-16 |
AU693576B2 AU693576B2 (en) | 1998-07-02 |
Family
ID=20157803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU29002/95A Ceased AU693576B2 (en) | 1994-06-29 | 1995-06-27 | Peptide, a method of obtaining it and a pharmaceutical compound based on it |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0779076B1 (en) |
JP (1) | JP3668950B2 (en) |
CN (1) | CN1165336C (en) |
AT (1) | ATE290547T1 (en) |
AU (1) | AU693576B2 (en) |
CA (1) | CA2193969C (en) |
DE (1) | DE69534061T2 (en) |
DK (1) | DK0779076T3 (en) |
ES (1) | ES2239760T3 (en) |
HK (1) | HK1012551A1 (en) |
PT (1) | PT779076E (en) |
RU (1) | RU2067000C1 (en) |
WO (1) | WO1996002267A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU708084B2 (en) * | 1995-03-02 | 1999-07-29 | Immunotech Developments Inc. | Peptide and a method of obtaining it |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5868728A (en) * | 1995-02-28 | 1999-02-09 | Photogenesis, Inc. | Medical linear actuator for surgical delivery, manipulation, and extraction |
US6127339A (en) * | 1995-06-21 | 2000-10-03 | Asahi Kasei Kogyo Kabushiki Kaisha | Peptide for binding thereto a low density lipoprotein |
CN1200736A (en) | 1995-09-11 | 1998-12-02 | 第一制药株式会社 | Peptide derivatives |
WO2000043352A1 (en) | 1999-01-22 | 2000-07-27 | Pharmacore, Inc. | A method for the synthesis of compounds of formula 1 and derivatives thereof |
JP3930808B2 (en) * | 2001-02-27 | 2007-06-13 | ニューロタイド カンパニー リミテッド | Yeast-derived functional peptide having anti-stress function, anti-fatigue function, premenstrual syndrome and menstrual pain alleviating function and function as neurotrophic factor and method for producing the same |
US7473426B2 (en) | 2001-02-27 | 2009-01-06 | Yun Seok Choe | Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract |
US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
CA2667155C (en) | 2006-11-10 | 2016-05-10 | Cara Therapeutics, Inc. | Synthetic peptide amides |
US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
US8906859B2 (en) | 2006-11-10 | 2014-12-09 | Cera Therapeutics, Inc. | Uses of kappa opioid synthetic peptide amides |
WO2015100376A1 (en) | 2013-12-27 | 2015-07-02 | Stealth Peptides International, Inc. | Pharmaceutically relevant aromatic-cationic peptides |
CA2978905A1 (en) | 2015-03-06 | 2016-09-15 | Stealth Biotherapeutics Corp | Processes for preparing pharmaceutically relevant peptides |
KR102429287B1 (en) * | 2015-12-10 | 2022-08-05 | 가부시끼가이샤 메니콘 | Peptide composition |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8005121A (en) * | 1979-09-20 | 1981-03-24 | Erba Farmitalia | ORGANICALLY ACTIVE PEPTIDES. |
IE56021B1 (en) * | 1982-10-13 | 1991-03-27 | Akzo Nv | Peptides |
JPS59181293A (en) * | 1983-03-31 | 1984-10-15 | Kyowa Hakko Kogyo Co Ltd | Novel physiologically active proteinous substance |
FR2546756B1 (en) * | 1983-06-03 | 1985-11-29 | Centre Nat Rech Scient | NOVEL IMMUNOSTIMULATING DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS |
GB2146026A (en) * | 1983-09-07 | 1985-04-11 | Tanabe Seiyaku Co | Peptides and process for preparing the same |
DE3435727A1 (en) * | 1984-09-28 | 1986-04-10 | Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl | PHARMACOLOGICALLY ACTIVE PEPTIDES |
DE3841763A1 (en) * | 1988-12-12 | 1990-06-13 | Basf Ag | NEW TNF PEPTIDES |
DE3841761A1 (en) * | 1988-12-12 | 1990-06-13 | Basf Ag | NEW TNF PEPTIDES |
SE9300012D0 (en) * | 1993-01-05 | 1993-01-05 | Astra Ab | NEW PEPTIDES |
-
1994
- 1994-06-29 RU RU9494024278A patent/RU2067000C1/en active
-
1995
- 1995-06-27 AT AT95924554T patent/ATE290547T1/en not_active IP Right Cessation
- 1995-06-27 JP JP50356096A patent/JP3668950B2/en not_active Expired - Fee Related
- 1995-06-27 AU AU29002/95A patent/AU693576B2/en not_active Ceased
- 1995-06-27 CN CNB951943820A patent/CN1165336C/en not_active Expired - Fee Related
- 1995-06-27 EP EP95924554A patent/EP0779076B1/en not_active Expired - Lifetime
- 1995-06-27 DK DK95924554T patent/DK0779076T3/en active
- 1995-06-27 WO PCT/RU1995/000138 patent/WO1996002267A1/en active IP Right Grant
- 1995-06-27 DE DE69534061T patent/DE69534061T2/en not_active Expired - Lifetime
- 1995-06-27 PT PT95924554T patent/PT779076E/en unknown
- 1995-06-27 ES ES95924554T patent/ES2239760T3/en not_active Expired - Lifetime
- 1995-06-27 CA CA2193969A patent/CA2193969C/en not_active Expired - Fee Related
-
1998
- 1998-12-17 HK HK98113808A patent/HK1012551A1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU708084B2 (en) * | 1995-03-02 | 1999-07-29 | Immunotech Developments Inc. | Peptide and a method of obtaining it |
Also Published As
Publication number | Publication date |
---|---|
DE69534061D1 (en) | 2005-04-14 |
CN1165336C (en) | 2004-09-08 |
JP2001503011A (en) | 2001-03-06 |
CN1159758A (en) | 1997-09-17 |
DK0779076T3 (en) | 2005-07-11 |
EP0779076B1 (en) | 2005-03-09 |
EP0779076A1 (en) | 1997-06-18 |
JP3668950B2 (en) | 2005-07-06 |
CA2193969A1 (en) | 1996-02-01 |
PT779076E (en) | 2005-07-29 |
CA2193969C (en) | 2010-11-30 |
WO1996002267A1 (en) | 1996-02-01 |
ES2239760T3 (en) | 2005-10-01 |
HK1012551A1 (en) | 1999-08-06 |
ATE290547T1 (en) | 2005-03-15 |
AU693576B2 (en) | 1998-07-02 |
DE69534061T2 (en) | 2006-04-13 |
EP0779076A4 (en) | 1999-03-17 |
RU2067000C1 (en) | 1996-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2900295A (en) | Peptide, a method of obtaining it and a pharmaceutical compound based on it | |
KR0139632B1 (en) | Peptides having brady kinine - inhibiting activity | |
UA48974C2 (en) | Peptide and method of its production | |
RU95108559A (en) | PEPTID AND METHOD FOR ITS PRODUCTION | |
KR840002772A (en) | Synthesis of Peptides with Pituitary Growth Hormone Release | |
RU94024278A (en) | PEPTIDE AND METHOD FOR ITS PREPARATION | |
CA2214410A1 (en) | Peptide and a method of obtaining it | |
RU2006111491A (en) | NEW TUMOR COMPOUNDS | |
FR2364889A1 (en) | Pentapeptide encephalin analogues - for use as analgesics and antidepressants | |
ES536117A0 (en) | A PROCEDURE FOR PREPARING CYCLICAL HEPTAPEPTIDES AND HEXAPEPTIDES FOR VASOPRESSIN ANTAGONISTS | |
EP0189326A3 (en) | Derivatives of arginine vasopressin antagonists | |
EP0151016A3 (en) | Arginine vasopressin antagonists | |
EP0175323A2 (en) | Biologically active peptides, processes for preparing them and pharmaceutical compositions | |
TH2820B (en) | Synthetic peptides showing growth hormone-releasing activity of pituitary | |
TH1762A (en) | Synthetic peptides showing growth hormone-releasing activity of pituitary | |
TH1618A (en) | The process of fabricating octa-peptides against wasopressins |